Theodore J. Witek, Jr
2016
In 2016, Theodore J. Witek, Jr earned a total compensation of $1.4M as Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs at Innoviva, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $252,371 |
|---|---|
| Salary | $420,619 |
| Stock Awards | $681,902 |
| Other | $23,712 |
| Total | $1,378,604 |
Witek received $681.9K in stock awards, accounting for 49% of the total pay in 2016.
Witek also received $252.4K in non-equity incentive plan, $420.6K in salary and $23.7K in other compensation.
Rankings
In 2016, Theodore J. Witek, Jr's compensation ranked 6,677th out of 14,075 executives tracked by ExecPay. In other words, Witek earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,677 out of 14,075 | 53rd |
Division Manufacturing | 2,487 out of 5,489 | 55th |
Major group Chemicals And Allied Products | 810 out of 1,895 | 57th |
Industry group Drugs | 622 out of 1,538 | 60th |
Industry Pharmaceutical Preparations | 491 out of 1,176 | 58th |
Source: SEC filing on March 23, 2018.
Witek's colleagues
We found four more compensation records of executives who worked with Theodore J. Witek, Jr at Innoviva in 2016.